Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001111369) titled 'Bacterial mucosal immunotherapy for prevention of lower respiratory tract infections in preterm born infants- AUSTRALIA (BALLOON-AU)' on Sept. 8.

Study Type: Interventional

Study Design: Purpose: Prevention Allocation: Randomised controlled trial Masking: Blinded (masking used)

Primary Sponsor: The Kids Research Institute Australia

Condition: Lower Respiratory Tract Infections Lower Respiratory Tract Infections Respiratory - Other respiratory disorders / diseases

Intervention: Bactek (MV130, Inmunotek, Spain) MV130 is a mucosal bacterial immunotherapy (under the brand name of BACTEK(R) or Bacmune(R)),...